TOT BIOPHARM's Series B Round

TOT BIOPHARM raised a round of funding on August 08, 2018.

TOT BIOPHARM (东曜药业), aka Dongpu Pharmaceutical, focuses on the R&D, manufacturing, and marketing of high-end anti-tumor drugs. TOT BIOPHARM has 3 technology platforms: (1) monoclonal antibodie…

Articles about TOT BIOPHARM's Series B Round: